@inproceedings{inproceedings, title  = {{Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC)}},

 url = {{}},

 year = {{2024}},

 month = {{1}},

 author = {{Naqvi SAA and Faisal KS and Raina A and Khakwani KZR and Bin Riaz Z and Shah VS and Cobran EK and Singh P and Hussain SA and Bryce AH and Bin Riaz I}},

 volume = {{42}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{16}},

 note = {{Accessed on 2024/12/22}}}